title: Marine bacteria: potential sources for compounds to overcome antibiotic resistance.
abstract: Methicillin-resistant Staphylococcus aureus (MRSA) is the most problematic Gram-positive bacterium in the context of public health due to its resistance against almost all available antibiotics except vancomycin and teicoplanin. Moreover, glycopeptide-resistant S. aureus have been emerging with the increasing use of glycopeptides. Recently, resistant strains against linezolid and daptomycin, which are alternative drugs to treat MRSA infection, have also been reported. Thus, the development of new drugs or alternative therapies is clearly a matter of urgency. In response to the antibiotic resistance, many researchers have studied for alternative antibiotics and therapies. In this review, anti-MRSA substances isolated from marine bacteria, with their potential antibacterial effect against MRSA as potential anti-MRSA agents, are discussed and several strategies for overcoming the antibiotic resistance are also introduced. Our objective was to highlight marine bacteria that have potential to lead in developing novel antibiotics or clinically useful alternative therapeutic treatments.
authors: Marine Bioprocess Research Center, Pukyong National University, Busan 608-737, Republic of Korea.
authors: Sung-Hwan
authors: SH
authors: Eom
authors: Young-Mog
authors: YM
authors: Kim
authors: Se-Kwon
authors: SK
authors: Kim
mesh_terms: D000900:Anti-Bacterial Agents / Q000302:isolation & purification* / Q000494:pharmacology* / Q000627:therapeutic use; D059001:Aquatic Organisms / Q000737:chemistry* / Q000302:isolation & purification; D001419:Bacteria / Q000737:chemistry* / Q000302:isolation & purification; D024901:Drug Resistance, Multiple, Bacterial; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents